摘要 |
The present invention relates to labelled cMet binding peptides suitable for optical imaging in vivo. The peptides are labelled with a benzopyrylium dye suitable for imaging in the red to near-infrared region. Also disclosed are pharmaceutical compositions and kits, as well as in vivo imaging methods, especially of use in the detection, staging, diagnosis, monitoring of disease progression or monitoring of treatment of colorectal cancer (CRC). |
申请人 |
GE HEALTHCARE LIMITED;NAIRNE, ROBERT, JAMES, DORNETT;HEALEY, ANDREW, JOHN;JOHANNESEN, EDVIN, WILHELM |
发明人 |
NAIRNE, ROBERT, JAMES, DORNETT;HEALEY, ANDREW, JOHN;JOHANNESEN, EDVIN, WILHELM |